News | April 04, 2025
Avantor bags awards at Asia-Pacific Biopharma Excellence Awards 2025
Awards highlight Avantor's commitment to the Biopharma industry
Awards highlight Avantor's commitment to the Biopharma industry
The portfolio includes branded injectable cephalosporines for infectious diseases
The company expects to launch this product through its marketing partner in the near future
According to IQVIA sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) market achieved annual sales of approximately $39.3 mn
AstraZeneca Pharma India discontinues manufacturing of Imdur
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
The inspection has concluded with four observations
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
Subscribe To Our Newsletter & Stay Updated
